STRANGER HOLDINGS PLC Logo

STRANGER HOLDINGS PLC

Mining and developing uranium and strategic metals with near-term production projects in Africa.

STHP | IL

Overview

Corporate Details

ISIN(s):
GB00BYWLRL80
LEI:
213800WE14587VRQ5Y10
Country:
United Kingdom
Address:
27-28 Eastcastle Street, W1W 8DH London
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Neo Energy Metals PLC, formerly Stranger Holdings PLC, is a mining and development company focused on the supply of uranium and strategic metals. The company's mission is to become an established, profitable uranium production company with multiple mining operations across Africa. Its primary asset is the Henkries Uranium project in South Africa, which it describes as a high-grade project capable of near-term production. The company transitioned from its previous form as an investment vehicle to its current operational focus following a reverse takeover.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 16:30
Report Publication Announcement
Update on Audit Progress and Trading Resumption
English 14.8 KB
2025-09-03 17:00
Report Publication Announcement
Annual Report, Accounts and Audit Progress Update
English 17.6 KB
2025-07-11 12:30
Board/Management Information
Corporate Update
English 23.0 KB
2025-07-09 15:30
Board/Management Information
Change in South African Transfer Secretary
English 13.8 KB
2025-07-03 16:40
Board/Management Information
Resignation of Director
English 16.5 KB
2025-06-30 16:35
Regulatory News Service
NEO to Complete Fast-Track Listing on the JSE
English 14.3 KB
2025-05-16 18:48
Declaration of Voting Results & Voting Rights Announcements
Correction - Shares on Issue and Voting Rights
English 17.2 KB
2025-05-16 08:00
Board/Management Information
Appointment of New South African based CEO
English 19.9 KB
2025-05-16 08:00
Share Issue/Capital Change
Issue of Equity - AUO Issue and Advisor Shares
English 16.5 KB
2025-05-15 17:18
Share Issue/Capital Change
Applications Lodged for Key Regulator Approvals
English 17.4 KB
2025-05-13 11:03
Regulatory News Service
Key SARB Approvals for Beisa Uranium Acquisition
English 17.1 KB
2025-03-11 11:15
Share Issue/Capital Change
Cash Payment and Share Issuance on Beisa Projects
English 19.2 KB
2025-03-10 09:00
Legal Proceedings Report
Further Agreement Signed for Beisa Uranium
English 14.3 KB
2025-03-10 08:00
Share Issue/Capital Change
Key Conditions Satisfied on B-BBEE Transaction
English 14.4 KB
2025-03-07 12:00
Share Issue/Capital Change
Formal Documents Signed for Henkries South Uranium
English 19.5 KB

Automate Your Workflow. Get a real-time feed of all STRANGER HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for STRANGER HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel NRGN
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland OCS
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea 244460
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea 382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea 476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan 4564
Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea 394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy OJM

Talk to a Data Expert

Have a question? We'll get back to you promptly.